Account wins

Centron has announced the following new agency of record assignments. Eisai has selected Centron as the advertising agency of record for their CTCL oncology portfolio, which includes ONTAK (denileukin diftitox), Targretin (bexarotene) capsules, and Targretin (bexarotene) gel 1.1%. Millennium Pharmaceuticals, has awarded Centron the advertising agency of record assignment for Velcade (bortezomib) for injection, their product for multiple myeloma and mantle cell lymphoma. Centron also announces that they have received additional assignments from Stiefel Laboratories, with agency of record assignments for Soriatane (acitretin), MimyX Cream, Olux-E (clobetasol propianate) Foam 0.05%, Verdeso (desonide) Foam, 0.05%, Olux (clobetasol propionate) Foam, 0.05%, and Luxiq (betamethasone valerate) Foam, 0.12%.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.